已发表论文

MDMX 在癌症中的作用:p53 的伙伴和 p53 独立的效应子

 

Authors Lin W, Yan Y, Huang Q, Zheng D 

Received 15 September 2023

Accepted for publication 8 December 2023

Published 31 January 2024 Volume 2024:18 Pages 61—78

DOI https://doi.org/10.2147/BTT.S436629

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Doris Benbrook

Abstract: The p53 tumor suppressor protein plays an important role in physiological and pathological processes. MDM2 and its homolog MDMX are the most important negative regulators of p53. Many studies have shown that MDMX promotes the growth of cancer cells by influencing the regulation of the downstream target gene of tumor suppressor p53. Studies have found that inhibiting the MDMX-p53 interaction can effectively restore the tumor suppressor activity of p53. MDMX has growth-promoting activities without p53 or in the presence of mutant p53. Therefore, it is extremely important to study the function of MDMX in tumorigenesis, progression and prognosis. This article mainly reviews the current research progress and mechanism on MDMX function, summarizes known MDMX inhibitors and provides new ideas for the development of more specific and effective MDMX inhibitors for cancer treatment.

Keywords: MDMX, P53, cancer, inhibitors